Mometasone furoate nasal spray in the treatment of nasal polyposis in Chinese patients: A double-blind, randomized, placebo-controlled trial

International Forum of Allergy and Rhinology

Volumn 6, Issue 1, 2016, Pages 88-94

  Zhou, Bing ^a,b   He, Gang ^c   Liang, Jianping ^d   Cheng, Lei ^e   Mehta, Anish ^f   Liu, Shu ^f   Yu, Wenbo ^f   Wang, Zaiqi ^f   Han, Demin ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^d PEOPLE'S HOSPITAL OF GUANGXI ZHUANG AUTONOMOUS REGION   (China)

^e NANJING MEDICAL UNIVERSITY   (China)

^f MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Anterior rhinorrhea; Intranasal corticosteroids; Mometasone furoate; Nasal congestion; Nasal obstruction; Nasal polyps; Postnasal drip; Randomized controlled trial

Indexed keywords

BECLOMETASONE DIPROPIONATE; MOMETASONE FUROATE; PLACEBO; ANTIINFLAMMATORY AGENT; NOSE SPRAY;

ADULT; AGED; ARTICLE; CHINESE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; EPISTAXIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOSE OBSTRUCTION; NOSE POLYP; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VERY ELDERLY; ADOLESCENT; CHINA; CLINICAL TRIAL; DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; NASAL POLYPS; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; CHINA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOMETASONE FUROATE; NASAL POLYPS; NASAL SPRAYS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84953720046     PISSN: 20426976     EISSN: 20426984     Source Type: Journal    
DOI: 10.1002/alr.21650     Document Type: Article

References (17)

1. Önerci TM, Ferguson BJ, eds. Nasal Polyposis: Pathogenesis, Medical and Surgical Treatment. Heidelberg: Springer-Verlag; 2010.
2. Dietz de Loos DA, Hopkins C, Fokkens WJ. Symptoms in chronic rhinosinusitis with and without nasal polyps. Laryngoscope. 2013;123:57-63.
3. Miwa T, Furukawa M, Tsukatani T, Costanzo RM, DiNardo LJ, Reiter ER. Impact of olfactory impairment on quality of life and disability. Arch Otolaryngol Head Neck Surg. 2001;127:497-503.
4. Soler ZM, Wittenberg E, Schlosser RJ, Mace JC, Smith TL. Health state utility values in patients undergoing endoscopic sinus surgery. Laryngoscope. 2011;121:2672-2678.
5. Kern RA, Schenck HP. The relation of chronic paranasal sinus infection to diseases of the lower respiratory tract. Trans Am Clin Climatol Assoc. 1933;49:203-208.
6. Henriksson G, Westrin KM, Karpati F, Wikstrom AC, Stierna P, Hjelte L. Nasal polyps in cystic fibrosis: clinical endoscopic study with nasal lavage fluid analysis. Chest. 2002;121:40-47.
7. Zeitz HJ. Bronchial asthma, nasal polyps, and aspirin sensitivity: Samter's syndrome. Clin Chest Med. 1988;9:567-576.
8. Rudmik L, Schlosser RJ, Smith TL, Soler ZM. Impact of topical nasal steroid therapy on symptoms of nasal polyposis: a meta-analysis. Laryngoscope. 2012;122:1431-1437.
9. Small CB, Stryszak P, Danzig M, Damiano A. Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis. J Allergy Clin Immunol. 2008;121:928-932.
10. Stjärne P, Mösges R, Jorissen M, et al. A randomized controlled trial of mometasone furoate nasal spray for the treatment of nasal polyposis. Arch Otolaryngol Head Neck Surg. 2006;132:179-185.
11. Meng J, Zhou P, Liu Y, et al. The development of nasal polyp disease involves early nasal mucosal inflammation and remodelling. PLoS One. 2013;8:e82373.
12. U.S. Food and Drug Administration. Department of Health and Human Services. International Conference on Harmonisation; Good Clinical Practice: Consolidated Guideline; Availability. [Docket No. 95D-0219]. Fed Regist. 1997;62:25692-25709. http://www.gpo.gov/fdsys/pkg/FR-1997-05-09/pdf/97-12138.pdf. Accessed September 8, 2015.
13. Rudmik L, Hoy M, Schlosser RJ, et al. Topical therapies in the management of chronic rhinosinusitis: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2013;3:281-298.
14. Van Zele T, Claeys S, Gevaert P, et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy. 2006;61:1280-1289.
15. Tikaram A, Prepageran N. Asian nasal polyps: a separate entity? Med J Malaysia. 2013;68:445-447.
16. Zhang N, Van Zele T, Perez-Novo C, et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. J Allergy Clin Immunol. 2008;122:961-968.
17. Hao J, Pang YT, Wang DY. Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate. Otolaryngol Head Neck Surg. 2006;134:267-275.